Latest News

Southwest Airlines (NYSE:LUV) has arranged a new $500 million senior secured term loan facility. The facility is intended to increase the airline’s liquidity and financial flexibility. The move comes as the company faces higher fuel costs linked to ongoing geopolitical tensions in the Middle East. Southwest Airlines, trading at $38.75, is taking a fresh look at its balance sheet as operating pressures build. The stock is up 24.6% over the past year, although it has seen a 24.7% decline over...

Liontown (ASX:LTR) is back in focus after completing its shift to 100% underground mining, reporting half year sales of A$207.54 million and a wider net loss of A$183.97 million. See our latest analysis for Liontown. The latest operational update and earnings release sit against a backdrop of strong momentum, with a recent 1-day share price return of 4.01% and a 1-year total shareholder return of 161.24% from a much lower base, while multi year total returns are more modest. If this lithium...

T-Mobile US (TMUS) just rolled out new device and value offers around Apple’s iPhone 17e and iPad Air, paired with entertainment bundles and travel perks that keep the focus squarely on customer acquisition and loyalty. See our latest analysis for T-Mobile US. Against this backdrop of new device offers and perks, T-Mobile US’s 90 day share price return of 11.39% and 8.92% year to date sit alongside a 1 year total shareholder return of 13.62% and a 5 year total shareholder return of 82.06%...

Wondering if Dell Technologies at around US$151.62 is still fairly priced, starting to look expensive, or offering value? This article is designed to help you frame that question clearly. The stock has seen strong momentum recently, with returns of 3.5% over 7 days, 22.1% over 30 days, 18.6% year to date, 61.4% over 1 year and 332.1% over 3 years. That naturally raises questions about what is already priced in. Recent coverage has focused on Dell as a key name in large scale computing and...

Toro Neurovascular previously announced that the U.S. FDA had granted 510(k) clearance for its Toro 88 Superbore Catheter, with Kaneka Medical America LLC leading the U.S. commercial launch following the device’s first successful clinical use by Dr. Satoshi Tateshima. This launch underscores Kaneka’s deeper involvement in the neurovascular device market, pairing Toro’s catheter technology with Kaneka’s established U.S. sales and clinical support network. We’ll now examine how Kaneka’s role...

Brenntag FY 2025 results: softer top line and a Q4 loss put margins in focus Brenntag (XTRA:BNR) has wrapped up FY 2025 with fourth quarter revenue of €3.5b and a basic EPS loss of €0.18, as net income excluding extra items came in at a loss of €25.8m. The company has seen quarterly revenue move from €3.99b in Q4 2024 to €3.51b in Q4 2025, while basic EPS went from €0.89 a share to a loss of €0.18 over the same period. This is setting the stage for investors to focus closely on how earnings...

If you are wondering whether Blue Owl Capital's share price now reflects good value or just fresh risks, you are not alone. This article is here to unpack that question clearly. Over the short term the stock has seen sharp moves, with a 7 day return of an 11.5% decline, a 30 day return of a 30.6% decline and a year to date return of a 42.8% decline, while the 1 year return sits at a 51.8% decline compared to a 6.4% gain over 5 years and a 1.9% decline over 3 years. Recent headlines around...

If you are wondering whether Braze's current share price lines up with its underlying worth, you are not alone. This article is designed to help you size up that gap. Braze's stock closed at US$18.77 recently, with returns of 6.0% over the last month but a 42.3% decline year to date and a 46.8% decline over the past year, which can reshape how investors think about both risk and potential upside. Recent coverage of Braze has focused on its role in customer engagement software and how...

Amphenol (APH) is back in focus after reporting record Q4 2025 sales of US$6.439b and earnings growth of more than 50%, with AI related data center demand standing out across already broad end market strength. See our latest analysis for Amphenol. The latest special call and shelf registration for new debt securities come after a very strong run, with the share price at US$133.92 and a 1 year total shareholder return of about 114%. However, the 1 month share price return of 7.03% and year to...

Gas supply disruptions in Qatar have led the Qatalum aluminum plant, a major joint venture of Norsk Hydro (OB:NHY), to cut production to 60% capacity. Qatalum avoided a full shutdown after QatarEnergy resumed limited gas supply under an updated agreement. The event directly affects Norsk Hydro’s joint venture income and contributes to tighter global aluminum supply conditions. Norsk Hydro is a fully integrated aluminum company, with Qatalum playing an important role in its global smelting...

If you are wondering whether Mohawk Industries at around US$102.55 is a potential bargain or a value trap, you are not alone. The stock has seen a 24.0% decline over the last 30 days and is down 10.3% over the past year, even though the 3 year return sits at 8.7%. Recent headlines have focused on Mohawk Industries' position in the flooring and broader consumer durables market, including how it is responding to shifts in housing activity and renovation demand. This context has kept attention...

Recent share performance and business snapshot Under Armour (UAA) has had a mixed run recently, with the stock down over the past month but positive over the past 3 months. This may prompt investors to reassess the story. The company generated revenue of about US$4.98b and reported a net loss of roughly US$519.71 million, while long term total returns over 3 and 5 years have been negative. This highlights ongoing turnaround questions. See our latest analysis for Under Armour. At a share price...

Why Medacta Group’s latest earnings matter for shareholders Medacta Group (SWX:MOVE) has just reported its 2025 results, with revenue of €684 million, EBITDA margin at 29%, net profit up 31% year over year, and a proposed dividend of CHF 1.10 per share, almost 60% higher. See our latest analysis for Medacta Group. At a share price of CHF155.8, Medacta’s 5.7% 1 month share price return sits against a modestly positive 3 month move of 3.0% and a much stronger 1 year total shareholder return of...

Event context and recent share performance Hanover Insurance Group (THG) has been on investors’ radar after recent share swings, including a roughly 6% decline over the past 3 months and a small gain over the past month. See our latest analysis for Hanover Insurance Group. At a share price of US$173.39, Hanover Insurance Group’s recent 1 day and 7 day share price declines sit against a modest 1 year total shareholder return of 4.5% and a strong 3 year total shareholder return of 53.4%. This...

In early March 2026, Box, Inc. reported higher quarterly and full-year revenue alongside lower net income, issued new earnings guidance for fiscal 2027, and confirmed it had completed a multi-year share repurchase totaling US$1.28 billion for about a third of its shares. The combination of revenue growth, reduced profitability, and large-scale buybacks gives investors fresh information on how Box is balancing expansion, earnings, and capital returns. Next, we’ll examine how Box’s new revenue...

Butler National (BUKS) has reported Q3 2026 revenue of US$26.9 million and basic EPS of US$0.10, set against trailing twelve month revenue of US$91.9 million and EPS of US$0.30 that came with 44.1% earnings growth and a 21.4% net margin over the past year. The company has seen quarterly revenue move from US$21.2 million in Q3 2025 to US$26.9 million in Q3 2026 and basic EPS from US$0.05 to US$0.10 across the same periods, with trailing net income reaching US$19.7 million, which positions the...

Guidance points to profit to loss swing Star Plus Legend Holdings (SEHK:6683) has guided for a consolidated loss of up to CN¥52.0 million for 2025, compared with a consolidated profit of CN¥50.2 million for 2024. The board links this shift mainly to slower IP content launches affecting its IP creation segment, lower gross margins in the expanding new retail business, and a non cash impairment provision on certain trade receivables tied to recent geopolitical developments. See our latest...

In recent weeks, Vital Farms reported weaker-than-expected quarterly earnings, prompting multiple law firms to launch securities investigations while the stock touched a new 52-week low and sector-wide pressures weighed on sentiment. Amid these legal probes and analyst concerns, Director Karl Khoury’s purchase of 5,000 additional shares stands out as a contrasting insider confidence signal. We’ll now examine how the earnings disappointment and resulting legal investigations might reshape...

Develop Global (ASX:DVP) is back in focus after releasing half year results to December 31, 2025, reporting sales of A$170.53 million and net income of A$1.63 million, both above the prior period. See our latest analysis for Develop Global. That earnings update landed against a weaker near term backdrop, with a 1 day share price return showing a decline of 3.74% and a 30 day share price return showing a decline of 15.66%, while the 1 year total shareholder return of 58.02% points to much...

PDD Holdings recently drew heightened investor attention as analysts raised earnings estimates ahead of its upcoming March 2026 report, while expectations point to solid year-over-year growth in both earnings and revenue. This renewed optimism has emerged even as the company faces ongoing regulatory and data privacy scrutiny in both the U.S. and China, highlighting investors’ focus on its operational performance and global e-commerce positioning. We’ll now examine how this pre-earnings...

Factory closures put Kraft Heinz (KHC) regional footprint under the spotlight Kraft Heinz (KHC) has outlined plans to shut facilities in New Zealand that produce Wattie’s frozen vegetables, Gregg’s coffee, and various dips, an operational shift tied to challenging conditions and recent financial losses. The move, which could affect around 350 jobs, highlights how management is reshaping its regional footprint and raises fresh questions for investors about profitability, efficiency, and long...

In early March 2026, Tenaya Therapeutics reported a narrower full-year 2025 net loss of US$90.6 million and highlighted new preclinical data for TN-301 in Duchenne muscular dystrophy alongside a research collaboration with Alnylam Pharmaceuticals on up to 15 cardiovascular gene targets that could yield as much as US$1.13 billion in milestones. Together, these updates underscore how Tenaya is pairing emerging HDAC6 science in DMD and heart failure with a genetically guided partnership model...

HSBC’s decision to upgrade Millicom International Cellular (TIGO) from Hold to Buy, citing sustained operational execution and stronger cash flow, has put fresh attention on a stock some investors viewed as fully valued. See our latest analysis for Millicom International Cellular. That upgrade comes on the back of a sharp shift in sentiment, with a 38.83% 3 month share price return and a 163.61% 1 year total shareholder return suggesting momentum has been building rather than fading. If this...

Earlier this month, Universal Technical Institute reported that it beat its fiscal 2025 operational targets with double‑digit revenue growth while a director, Shannon Lei Okinaka, sold 10,000 shares, about one‑third of her direct holdings, for roughly US$347,414 in an open‑market transaction on March 6, 2026. These developments come as the company is funding an ambitious multi‑year campus expansion that is compressing near‑term profits but is intended to support higher long‑term revenue and...